OpenAI Invests in Biosecurity to Counter Threats

Strategic Investments in Biosafety and AI

In a world filled with numerous concerns, the ability of artificial intelligence to transform biology into a weapon is not always at the forefront of discussions. However, for some investors, this intersection represents a strategic priority. Recently, two startups focusing on the convergence of AI and biosafety have managed to attract significant funding during their initial rounds, with OpenAI among the main contributors.

Valthos, a company specializing in the development of AI systems to identify biological threats and design countermeasures, raised an impressive $30 million last fall. Based in New York, Valthos benefits from the support of influential funds such as Founders Fund and Lux Capital, in addition to that of OpenAI.

A few weeks after this success, Red Queen Bio, another company focused on biosafety through AI, secured $15 million in a seed funding round led by OpenAI. Other investors include Cerberus Ventures, Fifty Years, and Halcyon Futures. Red Queen Bio's philosophy is based on the idea that advancements in AI exponentially increase biological risks, necessitating defenses that evolve at a similar pace.

The Role of Non-Profit Organizations

In the non-profit sector, SecureBio, located in Cambridge, Massachusetts, also obtained significant funding through grants last year. Among these funds, $1.4 million was awarded by Coefficient Giving in December. SecureBio's stated goal is to protect the future against catastrophic pandemics.

Comparison with Overall AI Funding

Although these amounts may seem substantial, they remain modest compared to the massive investments in artificial intelligence. To illustrate, the two largest seed funding rounds in biosafety represent less than one-tenth of a percent of the $110 billion that OpenAI recently raised.

What is particularly remarkable is that these investments are directed towards relatively new areas for startups. According to data from Crunchbase, the term “biosafety” is beginning to appear in the descriptions of funded startups, although rarely in direct connection with AI. Historically, startups in this field have often focused on the agricultural sector.

Examples of Startups in Biosafety

For instance, ExoFlare, an Australian company, raised several million dollars two years ago to focus on monitoring biosafety risks in the livestock sector, including cattle, pigs, eggs, and poultry. Similarly, Daro, based in Nebraska, secured $1.1 million last year to monitor swine diseases.

The Challenges of Modern Biosafety

Recent startups in the field of biosafety, in addition to their focus on AI, stand out for the alarming scenarios they seek to prevent. Valthos, for example, emphasizes that the militarization of biology is progressing faster than the development of new treatments, a concerning situation identified by AI leaders as one of the major threats of our time. The company envisions a future where every threat to human health could be immediately detected and neutralized.

Red Queen Bio, on the other hand, highlights an equally concerning array of threats, reflected in its name. The Red Queen hypothesis, inspired by the book “Through the Looking-Glass,” illustrates the need for constant adaptation in the face of ever-evolving threats. In this narrative, the Red Queen explains that one must run as fast as possible just to stay in the same place, a metaphor that applies well to our modern era, particularly in the field of biosafety. Failing to keep pace could have potentially disastrous consequences.